Publication | Open Access

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial

Open-label TrialHypertensionCardiovascular DiseaseAntihypertensive TherapyClinical TrialsCardiovascular PharmacologyParallel GroupPharmacotherapyPharmacologic InterventionRenin-angiotensin-system InhibitorsMedicineCovid-19